First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 775 000 KRW 0.65% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 605 790.3 KRW. Compared to the current market price of 775 000 KRW, Samsung Biologics Co Ltd is Overvalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
605 790.3 KRW
Overvaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

14.9
P/S
P/S
Price to Sales
14.9
vs History
92
vs Industry
14
Median 3Y
25.4
Median 5Y
37.6
Industry
3.9
Forward
13.3
More Details
64.3
P/E
P/E
Price to Earnings
64.3
vs History
90
vs Industry
4
Median 3Y
114.5
Median 5Y
115.3
Industry
30.3
Forward
57.1
More Details
33.1
P/OCF
P/OCF
Price to OCF
33.1
vs History
85
vs Industry
18
Median 3Y
75.8
Median 5Y
99.3
Industry
23.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
4
Median 3Y
-202.8
Median 5Y
-129.7
Industry
26.9
More Details
5.8
P/B
P/B
Price to Book Value
5.8
vs History
77
vs Industry
14
Median 3Y
6.9
Median 5Y
6.9
Industry
2.5
More Details
14.7
EV/S
EV/S
Enterprise Value to Sales
14.7
vs History
92
vs Industry
13
Median 3Y
25
Median 5Y
37
Industry
3.8
Forward
13.1
More Details
30.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
30.2
vs History
92
vs Industry
11
Median 3Y
51.8
Median 5Y
87.9
Industry
7.7
More Details
33.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.9
vs History
92
vs Industry
8
Median 3Y
58.6
Median 5Y
70.4
Industry
16.8
Forward
32.1
More Details
48.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
48.8
vs History
80
vs Industry
8
Median 3Y
77.5
Median 5Y
87.6
Industry
22
Forward
43.6
More Details
32.6
EV/OCF
EV/OCF
Enterprise Value to OCF
32.6
vs History
85
vs Industry
17
Median 3Y
75.7
Median 5Y
98.3
Industry
21.1
More Details
96.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
96.9
vs History
38
vs Industry
6
Median 3Y
-237.2
Median 5Y
-86.6
Industry
27.6
More Details
3.9
EV/IC
EV/IC
Enterprise Value to IC
3.9
vs History
85
vs Industry
25
Median 3Y
4.6
Median 5Y
5
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Samsung Biologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Samsung Biologics Co Ltd
KRX:207940
55.2T KRW 14.9 64.3 33.9 48.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.8B USD 5.2 37 22.8 33.5
US
Danaher Corp
NYSE:DHR
182.6B USD 4.2 22.6 16.5 20.3
US
IQVIA Holdings Inc
NYSE:IQV
42.6B USD 2.8 31.4 17 26.2
CH
Lonza Group AG
SIX:LONN
37.8B CHF 5.6 57.8 19.8 29.1
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.7B USD 7 33.8 23.6 26.3
US
West Pharmaceutical Services Inc
NYSE:WST
26.5B USD 9 44.6 30.5 36.5
IE
ICON PLC
NASDAQ:ICLR
25.4B USD 3.1 41.5 17.6 27.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.4B EUR 7.1 76.2 32.8 53.8
US
Illumina Inc
NASDAQ:ILMN
19.4B USD 4.3 -16.7 55.8 -261.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.